U.S. Markets open in 3 hrs 41 mins

Verastem (VSTM) in Focus: Stock Adds 14% in Session

Zacks Equity Research

Verastem, Inc. (VSTM) was a big mover last session, as its shares rose roughly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend of the company since May 8, as the stock is now up over 44%.

In the last 30 days, the company witnessed four negative estimate revisions and the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Verastem currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. (GILD), ANI Pharmaceuticals, Inc. (ANIP) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

VERASTEM INC (VSTM): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

Zacks Investment Research